SCHEMBL17177325

SCHEMBL17177325

Cc1cc(-c2ncc(NS(C)(=O)=O)cc2-c2ccc(N)c(C=N)c2)ccc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.36
▸ PTGS2 P35354 2/20 0.36
▸ ALOX5AP P20292 2/20 0.36
▸ FEN1 P39748 2/20 0.36
▸ KIT P10721 4/20 0.36
▸ PTGS1 P23219 1/20 0.35
▸ PIK3CB P42338 1/20 0.34
▸ TYRO3 Q06418 2/20 0.34
▸ BTK Q06187 2/20 0.34
▸ CLK4 Q9HAZ1 2/20 0.34
▸ KDR P35968 2/20 0.34
▸ AURKA O14965 1/20 0.34
▸ DAPK3 O43293 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ PRKD3 O94806 1/20 0.34
▸ MAP4K4 O95819 1/20 0.34
▸ PAK4 O96013 1/20 0.34
▸ NTRK1 P04629 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ RET P07949 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17177311 0.85 BTK (0.41) PTGS2KITPTGS1PIK3CBTYRO3
SCHEMBL18306350 0.85 TGFBR1 (0.39) ABL1KITTYRO3BTKCLK4
SCHEMBL18306360 0.83 IRAK4 (0.35) PTGS2PTGS1TYRO3BTKCLK4
SCHEMBL18306344 0.82 MAP4K4 (0.37) ABL1PTGS2ALOX5APFEN1KIT
SCHEMBL18306367 0.82 AURKA (0.37) ABL1PTGS2ALOX5APFEN1PTGS1
SCHEMBL18306348 0.82 RPS6KA3 (0.37) PTGS2ALOX5APFEN1PTGS1TYRO3
SCHEMBL18306345 0.81 PTGS2 (0.39) PTGS2ALOX5APFEN1PTGS1TYRO3
SCHEMBL18306335 0.80 DHODH (0.38) KITTYRO3BTKCLK4ACVR1
SCHEMBL18306440 0.79 AURKA (0.34) PTGS2ALOX5APFEN1KITPTGS1
SCHEMBL24715961 0.77 KDM1A (0.36) TYRO3BTKCLK4KDRAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015157093-A1 2,3-DISUBSTITUTED PYRIDINE COMPOUNDS AS TGF-BETA INHIBITORS AND METHODS OF USE RIGEL PHARMACEUTICALS, INC. (US) 2015-10-15 — — WO disclosed
Send feedback